Back to search

Article

Loss of HMCES is synthetic lethal with APOBEC activity in cancer cells

2021-02-06

Abstract excerpt

Analysis of cancer mutagenic signatures provides information about the origin of mutations and can inform the use of clinical therapies, including immunotherapy. In particular, APOBEC3A (A3A) has emerged as a major driver of mutagenesis in cancer cells and its expression results in DNA damage and susceptibility to treatment with inhibitors of the ATR and CHK1 checkpoint kinases. Here we report the implementation o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4285e23c-48a2-52b3-bd4f-be8af834e372
DOI
10.1101/2021.02.05.429803
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Loss of HMCES is synthetic lethal with APOBEC activity in cancer cellsDOI 10.1101/2021.02.05.429803
Select a neighboring publication to make it the new centre.